The News Review:

- Pfizer leads industry in research accreditation
- PPD sells unit to Charles River for $46 mln
- CardioNet to buy Biotel enters clinical research
- PhRMA Honors Gardasil(r) Researchers With Discoverers Award
- Research and Markets: Contract Research utsourcing – Global …
- Pfizer Gets Accreditation For Protection f Human Rights In …

Pfizer leads industry in research accreditation
TheDay
announced Friday that three of its worldwide clinical research units including one in Connecticut are the first in the pharmaceutical industry accredited for ensuring the protection of humans taking part in early drug-testing trials. Pfizer said its clinical-trial programs in New Haven Belgium and Singapore have been accredited by the Association for the Accreditation of Human Research Protection Programs which it described as an independent group that promotes ethical research. Martin Mackay president of Pfizer Global Research & Development headquartered in New London said the accreditation shows the company's “continuing commitment to maintain the highest global standards for research. ””We are very pleased that Pfizer took a leadership position by demonstrating its commitment to human-research protections” said Felix Khin-Maung-Gyi chief executive of Maryland-based Cheseapeake Research Review a group that reviews the ethics and scientific rigor of institutional research. Pfizer said more than 150 hospitals universities and other institutions have been accredited for the ethical conduct of early-stage research also known as Phase 1.

PPD sells unit to Charles River for $46 mln
Reuters
5 mln April 3 (Reuters) – Clinical-research service provider Pharmaceutical Product Development Inc (PPDI. ) sold a pre-clinical research unit to rival Charles.

CardioNet to buy Biotel enters clinical research
mobihealthnews
CardioNet is particulary interested in Biotel’s Agility Centralized Research Services which is based in Chicago and provides ECG monitoring services to the medical device and pharma industries as well as to contract research and academic research organizations. The deal pending customer closing conditions as well as approval from Biotel’s shareholders who are set to receive $4. 82 per share of Biotel. Both companies’ boards have approved the deal.

PhRMA Honors Gardasil(r) Researchers With Discoverers Award
PR Newswire (press release)
“These extraordinary honorees certainly deserve this recognition because they are the heroes behind a medicine that helps patients prevent a life-threatening cancer before it can get started. PhRMA’s Discoverers Award recognizes scientists whose research and development of medicines have greatly benefited mankind and whose dedication to improving the quality of patients’ lives exemplifies the best among research-based company scientists today. Discoverers Award recipients are Merck’s Eliav Barr M. Vice President ncology Clinical Research who led the team that developed Gardasil’s clinical program; Merck’s Barry Buckland Ph. Vice President Research Bioprocess R&D whose department developed ways to safely manufacture large commercially viable amounts of the Gardasil vaccine; and Kathrin Jansen Ph.

Research and Markets: Contract Research utsourcing – Global …
Business Wire (press release)
This report analyzes the worldwide markets for Contract Research utsourcing in Millions of US$. The major Service segments analyzed are Drug Discovery and Clinical Research. The report provides separate comprehensive analytics for the US Europe Asia and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 219 companies including many key and niche players worldwide such as Criterium Inc.
Related from Aviationmonster: GE Aviation wins $1M German grant

Pfizer Gets Accreditation For Protection f Human Rights In …
RTT News
The AAHRPP accreditation was awarded to Pfizer’s clinical research units in New Haven CT Brussels Belgium and Singapore where the company conducts most of its Phase I clinical research. To earn the accreditation Pfizer participated in a rigorous 15-month examination of the clinical research practices at these units.